Towards Personalized MS Therapy: microRNAs as Early Indicators of Cladribine Response

New data presented at the Annual Meeting of the European Charcot Foundation show that circulating miRNAs represent promising mechanism-based biomarkers with the potential to enable more personalized monitoring and refinement of therapeutic strategies in multiple sclerosis.